A recent analysis reveals that the United States is the best country for tourist road trips.
Wave Life Sciences shares dropped sharply to start out the week after the company announced topline data from its ongoing midstage trial in Huntington’s disease.
PhaseBio Pharma shares jumped on Wednesday after the firm announced results from its midstage trial focused on novel therapies for cardiopulmonary orphan diseases.
Walgreens Boots Alliance released disappointing fiscal second-quarter financial results before the markets opened on Tuesday
In a period when the stock market has hit new all-time highs, trading volume has been extremely light in the month of August.
Source: This graphic was drawn by SKopp.[Public domain], via Wikimedia CommonsIn a world in which the wealthy–nations, companies, and people alike–borrow with great ease while the poor beg...
Ratings agencies missed the meltdown in the housing market and the rising debt tide that swept over European capitals.  We wanted to see if they are awarding Triple-A ratings to countries which did...
Treasury chief Tim Geithner is about to make an unannounced trip to China today to meet with the Chinese Vice Premier, Wang Qishan,  the official most involved with monetary policy.  This may...
Healthways announced that it will revise its guidance for 2015 due to lower than expected revenue from a single health plan contract and slower than expected business development for a couple...
After the markets closed Thursday, Nordstrom reported its fourth-quarter financial results.
In a sign of how perverse and debased the market’s reactions to simple news has become, NCC (NCC), the large regional bank, dropped from over $4 last Friday to $1.36 on Monday. Today, the shares...
Rivian stock plunged on Thursday following an announcement late Wednesday that the company plans to sell $1.5 billion in convertible notes.
U.S. companies announced more than 2.3 million job cuts in 2020, nearly half of which were attributed to the COVID-19 pandemic.
Source: ThinkstockCree, Inc. (NASDAQ: CREE) released its fiscal fourth-quarter earnings Tuesday after the markets closed. The company had a net loss of $0.42 per share on $382 million in revenue...
Catalyst Biosciences saw its shares practically triple in Tuesday’s session after the company announced a critical regulatory approval.